Organometálicos
Los compuestos organometálicos son aquellos que contienen enlaces entre átomos de carbono y metales, generalmente metales de transición, como el magnesio, zinc o platino. Estos compuestos poseen una amplia diversidad estructural y química, lo que les otorga una gran reactividad. Se utilizan principalmente en la síntesis orgánica, catalizando reacciones como la polimerización de monómeros y la formación de enlaces carbono-carbono. Además, los compuestos organometálicos tienen aplicaciones en la industria farmacéutica, como en la fabricación de medicamentos anticancerígenos, y en procesos industriales como la producción de plásticos y combustibles.
En CymitQuimica contamos con una amplia gama de compuestos organometálicos para investigación en química orgánica, catálisis y síntesis de nuevos materiales.
Se han encontrado 4422 productos de "Organometálicos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Gadobutrol Impurity 86 Hexafluorophosphate TFA Salt (Technical Grade)
CAS:Fórmula:C20H31N5O10·F6HP·C2HF3O2Peso molecular:501.49 145.97 114.023-(3-Aminopropyl)- Cyclobutanecarboxylic Acid HCl
CAS:Fórmula:C8H15NO2·HClPeso molecular:157.21 36.46Gadoteridol
CAS:Gadoteridol (Gd-HP-DO3A) is a gadolinium-based MRI contrast agent that can be used for central nervous system imaging.Fórmula:C17H29GdN4O7Pureza:99.77% - 99.91%Forma y color:SolidPeso molecular:558.69Ferric maltol
CAS:Ferric maltol is a non-salt oral iron with better tolerance for those intolerant to other iron forms.Fórmula:C18H15FeO9Pureza:98.68%Forma y color:SolidPeso molecular:431.15Ref: TM-T13692
1mg56,00€2mg81,00€5mg119,00€10mg183,00€25mg354,00€50mg518,00€100mg723,00€200mg938,00€1mL*10mM (DMSO)131,00€Eurycomalactone
CAS:Eurycomalactone, from Eurycoma longifolia, inhibits NF-κB (IC50 0.5 μM), stops protein synthesis and cyclin D1, spares IκBα and IKK.Fórmula:C19H24O6Pureza:99.48% - 99.87%Forma y color:SolidPeso molecular:348.39NU6027
CAS:NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-Fórmula:C11H17N5O2Pureza:98.36%Forma y color:SolidPeso molecular:251.29Lobaplatin
CAS:Lobaplatin (D-19466) (D-19466) is a diastereometric mixture of platinum(II) complexe.Fórmula:C9H18N2O3PtPureza:98.00%Forma y color:SolidPeso molecular:397.33Gadopentetic acid
CAS:Gadopentetic acid (Gd-DTPA), a gadolinium complex, is a paramagnetic MRI contrast agent used in bolus i.v. injections for DCE-MRI.Fórmula:C14H20GdN3O10Pureza:98%Forma y color:White Crystalline PowderPeso molecular:547.57Bismuth Potassium Citrate-d8 (Bismuth Subcitrate-d8)
CAS:Fórmula:C6H4D4O7·Bi·3KPeso molecular:2*196.15 208.98 3*39.10Miriplatin
CAS:Miriplatin (SM-11355) (SM-11355) is a platinum complex used in TACE that has promise for the therapy of hepatocellular carcinoma (HCC).Fórmula:C34H68N2O4PtPureza:≥95%Forma y color:SolidPeso molecular:763.99PHD-1-IN-1
CAS:PHD-1-IN-1 is a potent inhibitor of hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme(IC50 = 0.034 μM).Fórmula:C13H8N4Pureza:99.74%Forma y color:SolidPeso molecular:220.23Ref: TM-T9627
1mg44,00€5mg96,00€10mg139,00€25mg245,00€50mg368,00€100mg552,00€200mg748,00€1mL*10mM (DMSO)96,00€DOTE (di-n-Octyltin bis(2-ethylhexyl) mercaptoacetate)-d4
CAS:Fórmula:C36H68O4S2SnD4Peso molecular:755.81Ammonium iron(III) citrate
CAS:Ammonium iron(III) citrate (Ferric ammonium citrate) is a physiological form of non-ferritin-bound iron that causes intracellular iron overload and iron death.Fórmula:C24H32Fe3N3O28Pureza:98%Forma y color:Ferric Ammonium Citrate Is A Yellowish Brown To Red Solid With A Faint Odor Of AmmoniaPeso molecular:978.055-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Used as an intermediate in the industrial preparation of non-ionic X-ray contrast agents such as Iohexol (I729500), Ioversol (I737000), Ioxilan (I737500), Iopamidol (I735600).<br>References Rongved, P., et al.: Carbohydrate Res., 297, 325 (1997),<br></p>Fórmula:C14H18I3N3O6Forma y color:NeatPeso molecular:705.02(S,S)-Oxaliplatin
CAS:Producto controlado<p>Applications The (S,S) Oxaliplatin isomer. Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Fórmula:C8H14N2O4PtForma y color:WhitePeso molecular:397.29(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Pureza:98%Peso molecular:252.10000610351562Oxaliplatin
CAS:Producto controlado<p>Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Fórmula:C8H14N2O4PtForma y color:White To Off-WhitePeso molecular:397.295-Amino-2,4,6-triiodoisophthalic Acid
CAS:Producto controlado<p>Impurity Iohexol EP Impurity K<br>Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.<br></p>Fórmula:C8H4I3NO4Forma y color:NeatPeso molecular:558.84Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate
CAS:Producto controlado<p>Impurity Oxaliplatin EP Impurity E<br>Stability Light Sensitive<br>Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.<br>References Gill, D.: Dev. Oncol., 17, 267 (1984);<br></p>Fórmula:C12H30N6O8Pt2Forma y color:White To Light YellowPeso molecular:776.56Potassium Trichloroammineplatinate
CAS:Producto controlado<p>Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.<br>References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);<br></p>Fórmula:K·Cl3H3NPtForma y color:NeatPeso molecular:357.57DOTA
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Fórmula:C16H28N4O8Forma y color:Light YellowPeso molecular:404.42Cyclic Iodixanol (90%)
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Fórmula:C33H41I5N6O14Pureza:90%Forma y color:NeatPeso molecular:1380.23Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Fórmula:C6H12N2O4PtForma y color:White To Off-WhitePeso molecular:371.25N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
CAS:Producto controlado<p>Impurity Iohexol USP Related Compound C<br>Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.<br>References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);<br></p>Fórmula:C14H19N3O8Forma y color:White To Off-WhitePeso molecular:357.325-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications An intermediate used in the synthesis of imaging agents such as Iohexol (I729500).<br>References Priebe, H., et al.: J. Clin. Pharm. Ther., 24, 227 (1999),<br></p>Fórmula:C16H20I3N3O7Forma y color:NeatPeso molecular:747.06[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum
CAS:<p>Applications [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y. et al.: Biomed. Pharmacther., 43, 261 (1989); Noji, M. et al.: J. Med. Chem., 24, 508 (1981); Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Fórmula:C6H14I2N2PtForma y color:NeatPeso molecular:563.08N1-(2-(2,3-Dihydroxypropoxy)-3-hydroxypropyl Iohexol
CAS:<p>Impurity Iohexol EP Impurity E<br>Applications N1-(2-(2,3-dihydroxypropoxy)-3-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Fórmula:C22H32I3N3O11Forma y color:NeatPeso molecular:895.221,1-Cyclobutanedicarboxylic Acid
CAS:<p>Applications 1,1-Cyclobutanedicarboxylic Acid is used in the design, studies and structural model of antitumor dicycloplatin a clinical cancer drug. Hydrolysis mechanism of second-generation anticancer drug carboplatin.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yang, X. Q., et al.: Science China: Chemistry, 53, 1346 (2010); Pavelka, M., et al.: Chem. Eur. J., 13, 10108 (2007)<br></p>Fórmula:C6H8O4Forma y color:NeatPeso molecular:144.13(3-Methoxypyridin-4-yl)boronic acid hydrate
CAS:Fórmula:C6H10BNO4Pureza:95.0%Forma y color:SolidPeso molecular:170.96{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid
CAS:Pureza:98%Peso molecular:227.07000733-(Methoxycarbonyl)thiophene-2-boronic acid
CAS:Pureza:95%Forma y color:SolidPeso molecular:185.99000549316406(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Fórmula:C13H12BClO3Pureza:95.0%Forma y color:SolidPeso molecular:262.54-Borono-2,6-difluorobenzoic acid
CAS:Fórmula:C7H5BF2O4Pureza:98%Forma y color:No data available.Peso molecular:201.92(4-Chloro-2-propoxyphenyl)boronic acid
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:214.44999694824223-Chloro-4-pyridineboronic acid hydrate
CAS:Fórmula:C5H7BClNO3Pureza:95.0%Forma y color:SolidPeso molecular:175.38(1-(Tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)boronic acid
CAS:Pureza:98%Peso molecular:181.99000549316406Des(2-Hydroxypropyl) Gadoteridol
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.<br>References Filippi, M. et al.: Chem. Comm., 50, 3453 (2014); Ferrauto, G. et al.: J. Am. Chem. Soc., 136, 638 (2014);<br></p>Fórmula:C14H23GdN4O6Forma y color:NeatPeso molecular:500.61(3-(Piperidin-1-yl)phenyl)boronic acid
CAS:Fórmula:C11H16BNO2Pureza:97%Forma y color:SolidPeso molecular:205.06(5-Cyano-1H-indol-2-yl)boronic acid
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:185.97999572753906(3-Chloro-5-propoxyphenyl)boronic acid
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:214.4499969482422(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
CAS:Pureza:95+%Peso molecular:294.1600036621094Dihydroxy Oxaliplatin-Pt(IV)
CAS:Producto controlado<p>Applications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.<br>References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),<br></p>Fórmula:C8H16N2O6PtForma y color:White To Light YellowPeso molecular:431.3013-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid
CAS:<p>Applications 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent.<br>References Petersein, J. et al.: Am. J. Roentgenol., 165, 1167 (1995);<br></p>Fórmula:C13H22N4O5Forma y color:White SolidPeso molecular:314.34(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Fórmula:C5H4BF2NO2Pureza:96%Forma y color:No data available.Peso molecular:158.9Iohexol
CAS:Producto controlado<p>Applications Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Fórmula:C19H26I3N3O9Forma y color:Off-WhitePeso molecular:821.14(4-(Decyloxy)phenyl)boronic acid
CAS:Pureza:97.0%Forma y color:SolidPeso molecular:278.20001220703125(4-((2-Isopropyl-5-methylphenoxy)methyl)phenyl)boronic acid
CAS:Pureza:96%Peso molecular:284.1600036621094Transplatin
CAS:<p>Applications Transplatin is the trans stereoisomer impurity of Cisplatin (C499500), an antineoplastic used in the treatment of sarcomas, some carcinomas, lymphomas, and germ cell tumors. Transplatin binds to DNA but does not exhibit the same useful pharmacological effect as its cis stereoisomer.<br>References Cersosimo, R.J.: Cancer Treat. Rev., 16, 195 (1989); Takeiri, A. et al.: Genes Environ., 29, 89 (2007); Giraud-Panis, M.-J. et al.: Pharmacol. Therap., 85, 175 (2000);<br></p>Fórmula:Cl2H6N2PtForma y color:Light YellowPeso molecular:300.04Iohexol-D5
CAS:Producto controlado<p>Stability Hygroscopic<br>Applications Deuterated Iohexol. Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Fórmula:C19H21D5I3N3O9Forma y color:NeatPeso molecular:826.17(2-Butoxy-4-fluorophenyl)boronic acid
CAS:Fórmula:C10H14BFO3Pureza:95.0%Forma y color:SolidPeso molecular:212.03N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol
CAS:Producto controlado<p>Impurity Iohexol EP Impurity D<br>Applications N1-(3-(2,3-dihydroxypropoxy)-2-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Fórmula:C22H32I3N3O11Forma y color:Off-WhitePeso molecular:895.22Gadopentetic Acid
CAS:Producto controlado<p>Applications: Gadopentetic Acid is a magnetic resonance contrast agent being used to develop a new platform for the delivery of therapeutic and imaging agents simultaneously to the colon.<br>References Jin, M., et al.: Mol. Pharm, 13, 2457-2465 (2016)<br></p>Fórmula:C14H20GdN3O10Forma y color:NeatPeso molecular:547.572-Fluoro-3-methoxyphenylboronic acid
CAS:Producto controlado<p>Applications 2-Fluoro-3-methoxyphenylboronic acid<br></p>Fórmula:C7H8BFO3Forma y color:NeatPeso molecular:169.95(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:319.1199951171875Ref: 10-F213351
1gA consultar2gA consultar5gA consultar100mgA consultar250mgA consultar500mgA consultarGadoteric Acid
CAS:Producto controlado<p>Applications Gadoteric Acid is used for magnetic resonance imaging.<br>References Gheuens, E., et al.: Invest. Radiol., 49, 505-508 (2014)<br></p>Fórmula:C16H25GdN4O8Forma y color:White To Off-WhitePeso molecular:558.64Oxaliplatin-d10
CAS:Producto controlado<p>Applications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Fórmula:C8H4D10N2O4PtForma y color:NeatPeso molecular:407.35
![5-Formyl-Benzo[b]thiophene-2-Boronic Acid Pinacol Ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F4Z%2Fthumb-webp%2FB-164008.webp&w=3840&q=75)
![Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD416765.webp&w=3840&q=75)
![[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC984525.webp&w=3840&q=75)
![{1-[(tert-Butoxy)carbonyl]-1,2,5,6-tetrahydropyridin-3-yl}boronic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF625887.webp&w=3840&q=75)
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT283945.webp&w=3840&q=75)
